Back
Novo Nordisk A/S Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
NVO
Novo Nordisk A/S
Last Price:
$60.68
Seasonality Move:
5.71%
7 Day Trial
ALL ACCESS PASS
$
7
Novo Nordisk A/S Stock Forecast
-
Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 22.3% based on the past 44 years of stock performance.
-
Novo Nordisk A/S has risen higher in 33 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Novo Nordisk A/S Stock Undervalued?The current Novo Nordisk A/S [NVO] share price is $62.33. The Score for NVO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NVO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk A/S Stock Go Up Next Year?
-
Over the next 52 weeks, Novo Nordisk A/S has on average historically risen by 22.3% based on the past 44 years of stock performance.
Novo Nordisk A/S Stock Rating
Buy
51
Novo Nordisk A/S (NVO)
is a Buy
Is Novo Nordisk A/S overpriced?
-
Novo Nordisk A/S has risen higher in 33 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Novo Nordisk A/S Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
93.80
52-Week Low:
43.08
Prediction Charts
Market Cap:
277B
Price in USD:
62.33
Volume:
43.4M
Beta:
0.48
Technical Analysis
SMA50:
50.62
SMA100:
53.24
SMA200:
59.01
52-Wk Change:
-24.97%
Stock Predictions
-
Is Novo Nordisk A/S stock public?Yes, Novo Nordisk A/S is a publicly traded company.
-
What is the Novo Nordisk A/S stock quote today?The Novo Nordisk A/S stock price is 62.33 USD today.
-
How to buy Novo Nordisk A/S stock online?You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-29 | 51.56 | 51.47 | 51.99 | 51.35 |
| Dec-30 | 51.52 | 51.22 | 51.67 | 51.07 |
| Dec-31 | 51.05 | 50.88 | 51.26 | 50.55 |
| Jan-2 | 51.68 | 52.39 | 52.41 | 51.41 |
| Jan-5 | 53.92 | 55.11 | 55.42 | 53.36 |
| Jan-6 | 57.18 | 56.26 | 58.15 | 56.02 |
| Jan-7 | 56.85 | 56.57 | 57.77 | 56.23 |
| Jan-8 | 57.04 | 57.34 | 57.91 | 57.01 |
| Jan-9 | 59.47 | 58.81 | 60.64 | 58.78 |
| Jan-12 | 60.14 | 59.86 | 60.30 | 59.10 |
| Jan-13 | 60.58 | 59.64 | 60.63 | 59.14 |
| Jan-14 | 58.84 | 58.91 | 59.75 | 58.34 |
| Jan-15 | 57.79 | 57.12 | 57.84 | 56.29 |
| Jan-16 | 59.91 | 62.33 | 62.40 | 59.24 |
Novo Nordisk A/S Earnings
Novo Nordisk A/S Earnings Report: Per Share Novo Nordisk A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk A/S Forecast Revenue Growth
Novo Nordisk A/S Stock Analysis: Historical quarterly revenues per share for Novo Nordisk A/S and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.45 per share.
* Novo Nordisk A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.